MDT

97.56

-1.22%↓

A

148.57

+2%↑

VEEV

239.64

-0.58%↓

HQY

94.29

-4.24%↓

PHR.US

17.17

+1.72%↑

MDT

97.56

-1.22%↓

A

148.57

+2%↑

VEEV

239.64

-0.58%↓

HQY

94.29

-4.24%↓

PHR.US

17.17

+1.72%↑

MDT

97.56

-1.22%↓

A

148.57

+2%↑

VEEV

239.64

-0.58%↓

HQY

94.29

-4.24%↓

PHR.US

17.17

+1.72%↑

MDT

97.56

-1.22%↓

A

148.57

+2%↑

VEEV

239.64

-0.58%↓

HQY

94.29

-4.24%↓

PHR.US

17.17

+1.72%↑

MDT

97.56

-1.22%↓

A

148.57

+2%↑

VEEV

239.64

-0.58%↓

HQY

94.29

-4.24%↓

PHR.US

17.17

+1.72%↑

Search

Veracyte Inc

Cerrado

SectorSalud

41.99 -3.58

Resumen

Variación precio

24h

Actual

Mínimo

41.94

Máximo

43.92

Métricas clave

By Trading Economics

Ingresos

12M

19M

Ventas

1.7M

132M

P/B

Media del Sector

111.872

87.826

Margen de beneficio

14.512

Empleados

824

EBITDA

4.4M

24M

Recomendaciones

By TipRanks

Recomendaciones

Comprar

Estimación a 12 meses

+5.92% upside

Dividendos

By Dow Jones

Próximas Ganancias

23 feb 2026

Estadísticas de Mercado

By TradingEconomics

Capitalización de Mercado

581M

3.4B

Apertura anterior

45.57

Cierre anterior

41.99

Noticias sobre sentimiento de mercado

By Acuity

89%

11%

360 / 372 Clasificación en Healthcare

Puntuación técnica

By Trading Central

Confianza

Weak Bearish Evidence

Veracyte Inc Gráfico

El rendimiento pasado no es un indicador fiable de resultados futuros.

Noticias Relacionadas

8 ene 2026, 23:08 UTC

Adquisiciones, fusiones, absorciones

Rio Tinto, Glencore in Talks to Form World's Biggest Miner -- 3rd Update

8 ene 2026, 21:39 UTC

Adquisiciones, fusiones, absorciones

Glencore, Rio Tinto Restart Merger Talks -- 2nd Update

8 ene 2026, 20:54 UTC

Adquisiciones, fusiones, absorciones

Glencore, Rio Tinto Restart Merger Talks -- Update

8 ene 2026, 20:44 UTC

Adquisiciones, fusiones, absorciones

Glencore, Rio Tinto Restart Merger Talks

8 ene 2026, 17:05 UTC

Adquisiciones, fusiones, absorciones

Chinese Anta Sports Products Offers to Buy Pinault Family's Stake in Puma, Reuters Says, Citing Unnamed Sources

8 ene 2026, 16:43 UTC

Principales Movimientos del Mercado

Babcock & Wilcox Shares Rise on Siemens Deal for Data Center Project

8 ene 2026, 23:44 UTC

Charlas de Mercado

Nikkei May Rise on Weaker Yen -- Market Talk

8 ene 2026, 23:37 UTC

Charlas de Mercado

Gold Steady, Underpinned by Geopolitical Risks -- Market Talk

8 ene 2026, 22:42 UTC

Charlas de Mercado

Global Forex and Fixed Income Roundup: Market Talk

8 ene 2026, 22:42 UTC

Charlas de Mercado

RBA Still Battling a Troubling Inflation Outlook, Says TD -- Market Talk

8 ene 2026, 22:30 UTC

Adquisiciones, fusiones, absorciones

Glencore, Rio Tinto Confirm Early Merger Talks -- Barrons.com

8 ene 2026, 21:53 UTC

Ganancias

These Stocks Moved the Most Today: Lockheed, Northrop, Alphabet, Applied Digital, Bloom Energy, Neogen, and More -- Barrons.com

8 ene 2026, 21:50 UTC

Charlas de Mercado

Basic Materials Roundup: Market Talk

8 ene 2026, 21:50 UTC

Charlas de Mercado

Auto & Transport Roundup: Market Talk

8 ene 2026, 21:10 UTC

Adquisiciones, fusiones, absorciones

Rio Tinto Says Current Expectation That Any Deal Would Involve Buying Glencore Via Scheme of Arrangement

8 ene 2026, 21:09 UTC

Charlas de Mercado

Oil Rises As Trump Said to Back Russia Sanctions Bill -- Market Talk

8 ene 2026, 21:09 UTC

Adquisiciones, fusiones, absorciones

Rio Tinto Confirms in Talks With Glencore Over Possible Merger

8 ene 2026, 20:21 UTC

Charlas de Mercado

U.S. Natural Gas Futures Down Despite Inventory Draw -- Market Talk

8 ene 2026, 19:44 UTC

Charlas de Mercado

Gold's Shine Masks Deep Drops in Canada Steel, Aluminum Exports -- Market Talk

8 ene 2026, 18:50 UTC

Charlas de Mercado

Mexico's Industrial Production Seen Lower in November -- Market Talk

8 ene 2026, 17:48 UTC

Ganancias

These Stocks Are Moving the Most Today: Lockheed, Northrop, Alphabet, Applied Digital, Bloom Energy, Neogen, and More -- Barrons.com

8 ene 2026, 17:20 UTC

Charlas de Mercado

Basic Materials Roundup: Market Talk

8 ene 2026, 17:20 UTC

Charlas de Mercado

Auto & Transport Roundup: Market Talk

8 ene 2026, 17:20 UTC

Charlas de Mercado

Health Care Roundup: Market Talk

8 ene 2026, 17:15 UTC

Charlas de Mercado

Global Commodities Roundup: Market Talk

8 ene 2026, 16:45 UTC

Charlas de Mercado

Goldman Lifts 1H LME Copper Forecast -- Market Talk

8 ene 2026, 16:03 UTC

Charlas de Mercado

Global Equities Roundup: Market Talk

8 ene 2026, 16:03 UTC

Charlas de Mercado

Currency Markets Could Be Underpricing Medium-Term Risks -- Market Talk

8 ene 2026, 16:02 UTC

Charlas de Mercado

U.S. Natural Gas Inventories Fall As Expected -- Market Talk

8 ene 2026, 15:23 UTC

Adquisiciones, fusiones, absorciones

Paramount Defends Its Hostile Bid for Warner -- Update

Comparación entre iguales

Cambio de precio

Veracyte Inc Esperado

Precio Objetivo

By TipRanks

5.92% repunte

Estimación a 12 meses

Media 46.14 USD  5.92%

Máximo 50 USD

Mínimo 43 USD

De acuerdo con 8 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Veracyte Inc Dist en los últimos 3 meses.

Consenso

By TipRanks

Comprar

8 ratings

6

Comprar

1

Mantener

1

Vender

Puntuación técnica

By Trading Central

30.5 / 31.38Soporte y Resistencia

Corto Plazo

Weak Bearish Evidence

Medio plazo

Bearish Evidence

Largo Plazo

Weak Bearish Evidence

Sentimiento

By Acuity

360 / 372 Clasificación en Salud

Noticias sobre sentimiento de mercado

Coyuntura bajista notoria

Volatilidad

Por debajo de la media

Volumen de Noticias (RCV)

Media

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de Veracyte Inc

Veracyte, Inc. operates as a diagnostics company in the United States and internationally. The company offers Afirma Genomic Sequencing Classifier for cancerous thyroid nodules; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer Assay for breast cancer diagnosis; Percepta Nasal Swab Test for lung cancer diagnosis; and Envisia Genomic Classifier for diagnosing interstitial lung disease, including idiopathic pulmonary fibrosis. It is also developing Envisia Classifier, the nCounter analysis system; and LymphMark for lymphoma subtyping test. The company was formerly known as Calderome, Inc. and changed its name to Veracyte, Inc. in March 2008. Veracyte, Inc. was incorporated in 2006 and is headquartered in South San Francisco, California.
help-icon Live chat